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Background:  Gender disparities in the prognostic utility of several biomarkers have been reported for coronary heart disease (CHD). We 
conducted a study to identify biomarkers for assessing 5-yr risk of primary MI, stratified by sex.
Methods:  We screened 52 proteins using assays developed de novo in baseline serum from 617 Norwegian adults drawn from the Tromsø Study 
4, an observational health study. In this case-control design, subjects were CHD/diabetes-free at baseline (1994-95); 173 cases (57 female, 116 
male) experienced a first MI during 5-year follow-up. Proteins contributing prognostic information beyond factors in the Framingham risk score (FRS: 
age, total cholesterol, HDL, systolic blood pressure, and smoking status) in sex-specific strata were identified using multivariable logistic regression 
models selected by minimizing the Bayesian Information Criterion.
Results: The biomarker iCb3 independently predicted MI in women, (OR=0.6; p=0.007) but not men (OR=0.94; p=0.6) when adjusted for the FRS 
factors. When combined with the FRS factors, iCb3 significantly improved model fit (likelihood ratio test p=0.008) and discrimination (area under 
the ROC curve AUC=0.797) vs. a model with only FRS factors in women (AUC=0.775; p=0.04). Conversely, lipoprotein profile (LPP) independently 
predicted MI for men (adjusted OR=1.7; p=0.001), but not women (OR=0.99; p=0.95). In men, LPP improved fit vs. FRS factors alone (p=0.008) and 
discrimination (AUC=0.741 vs. 0.708; p=0.03). The combined iCb3 model (females) and LPP model (males) predictions had superior discrimination 
in the whole study (AUC=0.799) vs. the refit FRS model (AUC=0.779; p=0.02), and significant Net Reclassification Improvement (0.101; p<0.01). The 
FRS as published had an AUC of 0.752. Findings were confirmed using a bootstrap cross-validation technique to correct for possible over-fit.
Conclusions:  In this population, the lipoprotein profile added incremental utility to the Framingham risk factors for men. Elevated levels of a 
serum protein associated with homeostatic control of inflammation, complement iCb3, independently indicated lower risk of MI in women, a novel 
finding to be verified in other populations.
